1. Research Institute BCN-BRAIN

Director: prof. I.E.C. Sommer MD PhD
Central theme: Behavioral and Cognitive Neurosciences

The Research Institute BCN-BRAIN was established in 2005 and is part of the Graduate School of Medical Sciences and of the Research School of Behavioral and Cognitive Neurosciences. BCN-BRAIN promotes research that is aimed at understanding the function of the healthy brain and dysfunction of the nervous system with reference to neurological and psychiatric disorders. Research is focused on translational collaboration between lab-based (molecular- and cell biological) and hospital-based (clinical) researchers integrating different levels of neuroscience research.


2. Research Institute GUIDE

Director: prof.  J.G.W. Kosterink PhD
Central theme: Chronic Diseases and Drug Exploration

The main asset of the Groningen University Institute for Drug Exploration (GUIDE) is the integration of clinical, biomedical and pharmaceutical research stimulating translational research and researchers with a keen eye on the complete spectrum of biomedical research: from bed to bench to drugs. Ageing is a central theme as most chronic diseases are age-dependent. Research focuses mainly on 1. Lead discovery, development of new drugs, drug delivery and advanced formulation technology and 2. Translational research on molecular and cellular mechanisms underlying disease (etiology and pathophysiology) and on research related to treatment of disease, e.g. in the context of clinical trials and by using relevant animal models.


3. Cancer Research Center Groningen (CRCG)

Director: prof. M. van Vugt PhD
Central theme: Cancer Research

The Cancer Research Center Groningen (CRCG) organizes and facilitates high-quality, oncology-related research activities within the UMCG and University of Groningen. All research activities at CRCG share the overall perspective of ‘healthier and longer lives of cancer patients through imprOoved care’. Research is performed at the fundamental, translational and clinical levels and organized in a coherent and effective manner in several research programs to achieve fundamental, clinical and societal relevant research output. Ultimately this leads to personalized cancer therapy, thus reducing the unintended side effects of treatment on normal tissues and improving the quality of life of cancer patients.


4. Research Institute SHARE (Science in Healthy Ageing and healthcaRE)

Director: prof. M.J. Postma PhD
Central theme: Prevention in Health Research

SHARE’s mission is to identify determinants and consequences of illness and Healthy Ageing, conducted within inter-/multidisciplinary programs, in close connection with societal parties and often based on observational data. The institute investigates and evaluates factors and interventions that are population-, patient- and/or healthcare-system-related. It adds knowledge on prevention of and adaptation to disease, enhancing societal participation of patients with chronic somatic and mental disease and cost-effectiveness and efficacy of pharmaceutical, medical, life-style and psychosocial interventions. Notably, a life-course perspective is taken, addressing research questions spanning from the preconception period, through infancy, reproductive and working ages to old age.

 

5. Research Institute W.J. Kolff

Director: prof. Y. Ren MD PhD
Central theme: Biomaterials

The primary objective of the W.J. Kolff Institute for Biomedical Engineering and Materials Science is to bring together pre-clinical and clinical research groups and to establish a center of expertise for the entire stage of biomedical materials science and its application involving basic materials science, medical product development and clinical evaluation that will contribute to the long-lasting well-being of patients in need of biomaterial implants and extra-corporal support systems. Research is conducted within four thematic research programs each with their own specific theme: 1. Bioadhesion, biocompatibility and infection, 2. Nanobiotechnology and advanced therapeutic materials, 3. Restoring organ function by means of regenerative medicine and 4. Maintaining oral health and oral function.